Renal denervation: A novel non-pharmacological approach in heart failure

Journal of Cardiovascular Translational Research

Volumn 7, Issue 3, 2014, Pages 330-337

  Böhm, Michael ^a   Ewen, Sebastian ^a   Linz, Dominik ^a   Reil, Jan C ^a   Schirmer, Stephan ^a   Ukena, Christian ^a   Mahfoud, Felix ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cardiorenal syndrome; Heart failure; Renal denervation; Resistant hypertension; Sympathetic nervous system

Indexed keywords

NORADRENALIN;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; ARTICLE; BLOOD PRESSURE REGULATION; CARDIORENAL SYNDROME; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INSULIN RESISTANCE; KIDNEY DENERVATION; KIDNEY DYSFUNCTION; METABOLIC SYNDROME X; NONHUMAN; NORADRENALIN BLOOD LEVEL; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; RESISTANT HYPERTENSION; SIGNAL TRANSDUCTION; SLEEP DISORDERED BREATHING; SYMPATHECTOMY; TREATMENT RESPONSE; CARDIO-RENAL SYNDROME; HYPERTENSION, RENAL; INNERVATION; KIDNEY; PROCEDURES;

CARDIO-RENAL SYNDROME; HEART FAILURE; HUMANS; HYPERTENSION, RENAL; KIDNEY; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84899422482     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-014-9549-5     Document Type: Article

References (52)

1. Floras, J. S. (2009). Sympathetic nervous system activation in human heart failure: clinical implications of an updatedmodel. Journal of the American College of Cardiology, 54, 375-385.
2. Holmer, S., Rinne, B., Eckardt, K. U., Le Hir, M., Schricker, K., Kaissling, B., Riegger, G., & Kurtz, A. (1994). Role of renal nerves for the expression of renin in adult rat kidney. American Journal of Physiology, 266, F738-F745.
3. Hofmann, U., & Frantz, S. (2013). Basic How can we cure a heart "in flame"? A translational view on inflammation in heart failure. Basic Research in Cardiology, 108, 356.
4. Heineke, J., & Molkentin, J. D. (2006). Regulation of cardiac hypertrophy by intracellular signalling pathways. Nature Reviews Molecular Cell Biology, 7(8), 589-600. (Pubitemid 44325350)
5. Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984). Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New England Journal of Medicine, 311, 819-823. (Pubitemid 14035089)
6. Rector, T. S., Olivari,M. T., Levine, T. B., Francis, G. S., & Cohn, J. N. (1987). Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. American Heart Journal, 114, 148-152. (Pubitemid 17098554)
7. Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990). Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation, 82, 1724-1729. (Pubitemid 20367975)
8. Esler,M. (2010). The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. Journal of Applied Physiology, 108, 227-237.
9. DiBona, G. F.,& Sawin, L. L. (1991). Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. American Journal of Physiology, 260, R298-R305.
10. Campese, V. M. (1997). Neurogenic factors and hypertension in chronic renal failure. Journal of Nephrology, 10, 184-187.
11. Sobotka, P. A., Mahfoud, F., Schlaich, M. P., Hoppe, U. C., Böhm, M., & Krum, H. (2011). Sympatho-renal axis in chronic disease. Clinical Research in Cardiology, 100, 1049-1057.
12. Huggett, R. J., Scott, E. M., Gilbey, S. G., Stoker, J. B., Mackintosh, A. F., & Mary, D. A. (2003). Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation, 108, 3097-3101. (Pubitemid 38031798)
13. Mancia,G., Bousquet, P., Elghozi, J. L.,Esler,M., Grassi, G., Julius, S., Reid, J., & Van Zwieten, P. A. (2007). The sympathetic nervous system and the metabolic syndrome. Journal of Hypertension, 25, 909-920. (Pubitemid 46573105)
14. Sobotka, P. A.,Krum, H., Böhm,M., Francis, D. P.,&Schlaich,M. P. (2012). The role of renal denervation in the treatment of heart failure. Current Cardiology Reports, 14, 285-292.
15. Dunlap, M. E., & Sobotka, P. A. (2013). Fluid re-distribution rather than accumulation causes most cases of decompensated heart failure. Journal of the American College of Cardiology, 62, 165-166.
16. Peppard, P. E.,Young, T., Palta,M.,&Skatrud, J. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. New England Journal of Medicine, 342, 1378-1384. (Pubitemid 30262394)
17. Logan, A. G., Perlikowski, S.M.,Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S., & Bradley, T. D. (2001). High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. Journal of Hypertension, 19, 2271-2277. (Pubitemid 33135251)
18. McMurray, J. J., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M. A., Jaarsma, T., Køber, L., Lip, G. Y., Maggioni, A. P., Parkhomenko, A., Pieske, B. M., Popescu, B. A., Rønnevik, P. K., Rutten, F. H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P. T., Voors, A.A., Zannad, F., & Zeiher, A. (2012). ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal, 33, 1787-1847.
19. Ljungqvist, A., & Wågermark, J. (1970). The adrenergic innervation of intrarenal glomerular and extra-glomerular circulatory routes. Nephron, 7, 218-229.
20. Stella, A., & Zanchetti, A. (1991). Functional role of renal afferents. Physiological Reviews, 71, 659-682.
21. Katholi, R. E., Whitlow, P. L., Hageman, G. R., & Woods, W. T. (1984). Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. Journal of Hypertension, 2, 349-359. (Pubitemid 14004193)
22. Esler,M., Lambert, G., & Jennings, G. (1989). Regional norepinephrine turnover in human hypertension. Clinical and Experimental Hypertension. Part A, Suppl 1, 75-89. (Pubitemid 19159111)
23. Hausberg, M., Kosch,M., Harmelink, P., Barenbrock, M., Hohage, H., Kisters, K., Dietl, K. H., & Rahn, K. H. (2002). Sympathetic nerve activity in end-stage renal disease. Circulation, 106, 1974-1979. (Pubitemid 35176304)
24. Swedberg, K., Viquerat, C., Rouleau, J. L., Roizen,M., Atherton, B., Parmley,W.W., & Chatterjee, K. (1984). Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. American Journal of Cardiology, 54, 783-786. (Pubitemid 14006148)
25. Böhm, M., Beuckelmann, D., Brown, L., Feiler, G., Lorenz, B., Näbauer, M., Kemkes, B., & Erdmann, E. (1988). Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. European Heart Journal, 9, 844-852.
26. Böhm, M., Gierschik, P., Jakobs, K. H., Pieske, B., Schnabel, P., Ungerer, M., & Erdmann, E. (1990). Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation, 82, 1249-1265.
27. Goldstein, D. S., Brush, J. E., Jr., Eisenhofer, G., Stull, R., & Esler, M. (1988). In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation, 78, 41-48.
28. Böhm, M., La Rosée, K., Schwinger, R. H., & Erdmann, E. (1995). Evidence for reduction of norepinephrine uptake sites in the failing human heart. Journal of the American College of Cardiology, 25, 146-153.
29. Hasking, G. J., Esler, M. D., Jennings, G. L., Burton, D., Johns, J. A., & Korner, P. I. (1986). Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation, 73, 615-621. (Pubitemid 16081418)
30. Petersson,M., Friberg, P., Eisenhofer, G., Lambert, G., & Rundqvist, B. (2005). Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. European Heart Journal, 26, 906-913. (Pubitemid 40676571)
31. Page, I. H. (1934). The effect on renal efficiency of lowering arterial blood pressure in cases of essential hypertension and nephritis. Journal of Clinical Investigation, 13, 909-915.
32. Page, I. H., & Heuer, G. J. (1935). The effect of renal denervation on the level of arterial blood pressure and renal function in essential hypertension. Journal of Clinical Investigation, 14, 27-30.
33. Smithwick, R. H., & Thompson, J. E. (1953). Splanchnicectomy for essential hypertension; results in 1,266 cases. Journal of the American Medical Association, 152, 1501-1504.
34. Krum, H., Schlaich, M.,Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., Abraham, W. T., & Esler, M. (2009). Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet, 373, 1275-1281.
35. Symplicity HTN-1 Investigators. (2011). Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension, 57, 911-917.
36. Hering, D., Mahfoud, F., Walton, A. S., Krum, H., Lambert, G. W., Lambert, E. A., Sobotka, P. A., Böhm,M., Cremers, B., Esler,M. D., & Schlaich, M. P. (2012). Renal denervation in moderate to severe CKD. Journal of the American Society of Nephrology, 23, 1250-1257.
37. Symplicity HTN-2 Investigators, Esler,M. D., Krum, H., Sobotka, P. A., Schlaich, M. P., Schmieder, R. E., & Böhm, M. (2010). Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet, 376, 1903-1909.
38. Esler, M. D., Krum, H., Schlaich, M., Schmieder, R. E., Böhm, M., Sobotka, P. A., & Symplicity HTN-2 Investigators. (2012). Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation, 126, 2976-2982.
39. Ukena, C., Mahfoud, F., Kindermann, I., Barth, C., Lenski, M., Kindermann, M., Brandt, M. C., Hoppe, U. C., Krum, H., Esler, M., Sobotka, P. A., & Böhm, M. (2011). Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. Journal of the American College of Cardiology, 58, 1176-1182.
40. Brandt, M. C., Reda, S., Mahfoud, F., Lenski, M., Böhm, M., & Hoppe, U. C. (2012). Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. Journal of the American College of Cardiology, 60, 1956-1965.
41. Brandt, M. C., Mahfoud, F., Reda, S., Schirmer, S. H., Erdmann, E., Böhm, M., & Hoppe, U. C. (2012). Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. Journal of the American College of Cardiology, 59, 901-909.
42. Davies, J. E.,Manisty, C. H., Petraco, R., Barron, A. J., Unsworth, B., Mayet, J., Hamady, M., Hughes, A. D., Sever, P. S., Sobotka, P. A.,& Francis, D. P. (2013). First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. International Journal of Cardiology, 162, 189-192.
43. Fallick, C., Sobotka, P. A., & Dunlap, M. E. (2011). Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation. Circulation. Heart Failure, 4, 669-675.
44. Linz, D., Schotten, U., Neuberger, H. R., Böhm, M., & Wirth, K. (2011). Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm, 8, 1436-1443.
45. Linz, D., Mahfoud, F., Schotten, U., Ukena, C., Neuberger, H. R., Wirth, K., & Böhm, M. (2012). Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension, 60, 172-178.
46. Ahmed, H.,Miller,M. A., Dukkipati, S. R., Cammack, S., Koruth, J. S., Gangireddy, S., Ellsworth, B. A., D'Avila, A., Domanski, M., Gelijns, A. C., Moskowitz, A., & Reddy, V. Y. J. (2013). Adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of atrial fibrillation (H-FIB) study: clinical background and study design. Journal of Cardiovascular Electrophysiology, 24, 503-509.
47. Linz, D.,Wirth,K., Ukena, C.,Mahfoud, F., Pöss, J., Linz, B., Böhm, M., & Neuberger, H. R. (2013). Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. Heart Rhythm. doi:10.1016/j.hrthm.2013.07.015.
48. Ukena, C., Bauer, A., Mahfoud, F., Schreieck, J., Neuberger, H. R., Eick, C., Sobotka, P. A., Gawaz, M., & Böhm, M. (2012). Renal sympathetic denervation for treatment of electrical storm: first-inman experience. Clinical Research in Cardiology, 101, 63-67.
49. Schlaich, M. P., Bart, B., Hering, D., Walton, A., Marusic, P., Mahfoud, F., Böhm, M., Lambert, E. A., Krum, H., Sobotka, P. A., Schmieder, R. E., Ika-Sari, C., Eikelis, N., Straznicky, N., Lambert, G. W., & Esler, M. D. (2013). Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. International Journal of Cardiology, 168, 2214-2220.
50. Mahfoud, F., Cremers, B., Janker, J., Link, B., Vonend, O., Ukena, C., Linz,D., Schmieder, R., Rump, L. C., Kindermann, I., Sobotka, P. A., Krum, H., Scheller, B., Schlaich, M., Laufs, U., & Böhm, M. (2012). Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension, 60, 419-424.
51. Linz, D., Hohl, M., Nickel, A., Mahfoud, F., Wagner, M., Ewen, S., Schotten, U., Maack, C., Wirth, K., & Böhm, M. (2013). Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension, 62, 767-774.
52. Mahfoud, F., Schlaich, M., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., Hoppe, U. C., Vonend, O., Rump, L. C., Sobotka, P. A., Krum, H., Esler, M., & Böhm, M. (2011). Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation, 123, 1940-1946.